Recently, our group and others have shown that higher circulating concentrations of neurofilament light chain (NfL, a specific marker of neuroaxonal damage) is associated with increasing clinical stroke severity5, infarct size6,7 and poor stroke outcome5–7. This evidence concerns the gene NEFL and stroke disorder.